Family health history (FHH) screening plays a key role in disease risk identification and tailored disease prevention strategies. Primary care physicians (PCPs) are in a frontline position to provide personalized medicine recommendations identified through FHH screening; however, adoption of FHH screening tools has been slow and inconsistent in practice. Information is also lacking on PCP facilitators and barriers of utilizing family history tools with clinical decision support (CDS) embedded in the electronic health record (EHR).
View Article and Find Full Text PDFAim: To explore primary care physicians' views of the utility and delivery of direct access to pharmacogenomics (PGx) testing in a community health system.
Methods: This descriptive study assessed the perspectives of 15 healthcare providers utilizing qualitative individual interviews.
Results: Three main themes emerged: perceived value and utility of PGx testing; challenges to implementation in practice; and provider as well as patient needs.
Aim: To assess patient perceptions and utilization of pharmacogenomics (PGx) testing in an integrated community health system.
Methods: Fifty-seven patients completed an online survey assessing their experiences with PGx testing offered through two methods: a designated PGx clinic or direct access in-home testing.
Results: The majority of participants perceived PGx testing as helpful in their healthcare and reported understanding their results.